Skip to main content
. 2023 Jun 7;11:e15459. doi: 10.7717/peerj.15459

Table 2. Sequences quality and reads mapping of different samples.

Samples Clean reads Q30% GC% Mapped reads Unique mapped reads
LPS1 38,126,744 94.29% 50.65% 36,008,258 (94.44%) 34,901,177 (91.54%)
LPS2 35,203,444 93.77% 50.41% 33,152,407 (94.17%) 31,547,155 (89.61%)
LPS3 34,923,253 94.05% 49.92% 32,860,710 (94.09%) 31,834,282 (91.15%)
CLPS1 30,683,298 94.05% 49.73% 28,896,011 (94.18%) 27,837,621 (90.73%)
CLPS2 33,420,602 94.43% 50.11% 31,682,117 (94.80%) 30,692,212 (91.84%)
CLPS3 31,530,842 94.47% 50.23% 29,882,067 (94.77%) 28,985,826 (91.93%)
PolyIC1 32,413,772 94.56% 50.62% 30,796,719 (95.01%) 29,890,039 (92.21%)
PolyIC2 26,512,197 94.6% 51.07% 24,992,758 (94.27%) 24,153,693 (91.10%)
PolyIC3 36,393,528 94.18% 50.92% 34,436,214 (94.62%) 33,286,709 (91.46%)
CPolyIC1 30,683,298 94.05% 49.73% 29,116,185 (94.86%) 28,272,727 (92.12%)
CPolyIC2 33,420,602 94.43% 50.11% 27,466,988 (94.85%) 26,540,968 (91.65%)
CPolyIC3 31,530,842 94.47% 50.23% 27,094,064 (95.05%) 26,144,517 (91.71%)

Notes.

LPS1-3
LPS treatment group
CLPS1-3
Control group of LPS treatment
PolyIC1-3
ploy(I:C) treatment group
CPolyIC1-3
Control group of ploy(I:C) treatment